Medicine & Health

At the School of Medicine, orthopedic surgeon Eric W. Carson aims to increase diversity and mentorship in medicine.

A deep dive into federal medical data, conducted by researchers at the School of Medicine, found that COVID-19 is much deadlier and causes more health problem for patients than the seasonal flu does.

Washington University School of Medicine in St. Louis faculty members Randall J. Bateman, MD, Michael S. Diamond, MD and Scott Hultgren have been elected fellows of the National Academy of Inventors, the highest professional distinction accorded solely to academic inventors.

Researchers at Washington University School of Medicine in St. Louis have received a five-year $3.2 million grant to study the genetic basis of the musculoskeletal disorder scoliosis, and particularly how it affects African Americans and other underrepresented minorities.

School of Medicine scientists have identified a molecule that protects mice from brain infections caused by Venezuelan equine encephalitis virus, a mosquito-borne virus notorious for causing fast-spreading, deadly outbreaks in Mexico, Central America and northern South America.

A study led by School of Medicine researchers showed that, contrary to expectations, most people with severe COVID-19 do not suffer from unbridled inflammation. The findings suggest that anti-inflammatory therapies may not be helpful for most COVID-19 patients.

Although viruses such as herpes simplex can infect the eye’s cornea and Zika virus has been found in corneal tissue and tears, new School of Medicine research suggests the cornea can resist infection from the novel coronavirus.

The School of Medicine is a testing site for a phase 3 clinical research study to evaluate the safety and efficacy of an investigational COVID-19 vaccine candidate from the Janssen Pharmaceutical Companies. The school will enroll up to 500 adults ages 18 and older in the St. Louis region.

A new, international phase 3 clinical trial led by the Washington University School of Medicine and funded by the National Institutes of Health (NIH), will investigate the potential of three drugs to tame a dangerous inflammatory response seen in some COVID-19 patients.

School of Medicine researchers have received an $8.5 million grant to study the role of gut viruses in inflammatory bowel disease. Tools developed in the course of the project could accelerate research into other roles of the virome in health and disease.